Trial Profile
A Randomized, Placebo-controlled, Double-blind, Parallel-group, Exploratory Study of DSP-6952 in Patients with Irritable Bowel Syndrome with Constipation (Early Phase 2 Study)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Minesapride (Primary)
- Indications Constipation; Irritable bowel syndrome
- Focus Therapeutic Use
- Sponsors Sumitomo Dainippon Pharma
- 05 Jun 2018 Primary endpoint (Presence or absence of global relief) has been met, according to results presented at the Digestive Disease Week 2018.
- 05 Jun 2018 Primary endpoint (Presence or absence of relief of abdominal symptoms) has been met, according to results presented at the Digestive Disease Week 2018.
- 05 Jun 2018 Primary endpoint (Presence or absence of Increased frequency of bowel movements) has been met, according to results presented at the Digestive Disease Week 2018.